ClinicalTrials.gg
RecruitingNCT07153653Updated Sep 4, 2025

Managing Pregnancy Pain With Baduanjin Exercise

An interventional study of Prenatal Baduanjin Exercise Program in Pregnancy-related Low Back and Pelvic Pain and Pregnancy, sponsored by Peking Union Medical College Hospital. Recruiting at 1 site in China. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-04.

Sponsored by Peking Union Medical College Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Mar 2025, registered Jul 2025).
  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Pelvic Pain with a site in China — 5 open to participants now, 5 under way, 1 of them phase 3. Pelvic Pain · China.

Planned enrollment
9th of 12
84 · median 198
Started
2025
the only one that year
No phase
7 of 14
2 open now
Registered
13th of 14
by date
Lead sponsor
2 of 14
Peking Union Medical College Hospital

Among the 14 studies in Pelvic Pain with a site in China, this one is the 9th largest by planned enrollment of the 12 interventional ones that give a count, is the only one that started in 2025, is one of 7 with no phase, and was the 13th registered.

Pelvic Pain

377 studies on the registry are indexed under Pelvic Pain; 91 are open to participants now.

Browse Pelvic Pain studies →

Open to participants now

5 of the 14 studies in Pelvic Pain with a site in China are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 61 Pelvic Pain studies recruiting now, 22 (36%) set no upper age limit and 37 (61%) stop at 75 or younger; 5 take children under 18; 10 take healthy volunteers.

This study: 18 Years to 45 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Pelvic Pain with a site in China, or all of them as a file.
02

Study summary

This is a randomized controlled trial studying whether a 12-week Baduanjin exercise program (a traditional Chinese mind-body exercise) can reduce low back pain and improve quality of life in pregnant women.

03

Conditions studied

  • Pregnancy-related Low Back and Pelvic Pain
  • Pregnancy

Keywords

  • pregnancy-related Low back and pelvic pain
  • pregnancy
  • low back pain
  • pelvic girdle pain
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Single pregnancy (carrying one fetus).
  • Gestational age: 14-20 weeks at enrollment.
  • No to exercise during pregnancy (as determined by medical evaluation).

Exclusion criteria

Exclusion Criteria:

  • Adverse pregnancy symptoms:
  • Dizziness, blurred vision, vaginal bleeding, or other high-risk signs.
  • Pre-existing medical conditions: Orthopedic, cardiovascular, or psychiatric diseases; cognitive impairment.
  • Pregnancy complications: Preterm labor, placenta previa.
  • Inability to attend regular prenatal check-ups.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    Baduanjin Group

    Prenatal Baduanjin Exercise Program

    Behavioral: Prenatal Baduanjin Exercise Program

  • No intervention
    Standard Clinic Prenatal Care

Interventions

  • BehavioralPrenatal Baduanjin Exercise Program

    A structured 12-week program featuring Baduanjin, a traditional Chinese mind-body exercise involving gentle, flowing movements. Participants receive 24 online instructional sessions (approximately 2 s

06

What researchers measure

Primary outcomes

  1. Low Back Pain Severity

    Measured using Numerical Rating Scale (NRS) where 0 = no pain and 10 = worst imaginable pain. Assesses self-reported low back/pelvic girdle pain intensity.

    Time frame: Baseline, 6 weeks, post-intervention (12 weeks)

Secondary outcomes

  1. Back Disability

    Functional limitations measured using: Chinese Oswestry Disability Index. Higher scores indicate greater disability.

    Time frame: Baseline, 6 weeks, post-intervention (12 weeks)

  2. Pelvic Disability

    Functional limitations measured using: Pelvic Girdle Questionnaire. Higher scores indicate greater disability.

    Time frame: Baseline, 6 weeks, post-intervention (12 weeks)

  3. Urinary Incontinence

    Measured using: ICIQ-SF (International Consultation on Incontinence Questionnaire-Short Form)). Higher scores indicate worse symptoms/impact.

    Time frame: Baseline, 6 weeks, post-intervention (12 weeks)

  4. Urinary Incontinence Severity

    Measured using: IIQ-7 (Incontinence Impact Questionnaire-7). Higher scores indicate greater disability.

    Time frame: Baseline, 6 weeks, post-intervention (12 weeks)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Sep 2025, 6 months after the start.

Of 110 non-industry interventional studies with no phase under Pelvic Pain, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 30. This study's planned 6 months is below that.

Counting every sponsor, half of 114 studies reached it within 17 months; a quarter within 5 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 27, 2025
First posted
Sep 4, 2025
StartActual
Mar 13, 2025
Primary completionEst.
Sep 30, 2025
CompletionEst.
Jun 30, 2026
Last update
Sep 4, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07153653
Responsible party
Sponsor
First posted
Sep 4, 2025
Start date
Mar 13, 2025
Primary completion
Sep 30, 2025 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Sep 4, 2025

Study contacts

Liangkun Ma
Contact
maliangkun@pumch.cn
+8613021961166
Liangkun Ma
study chair · Chinese Academy of Medical Science & Peking Union Medical College Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion